Skip to Main Content
1-877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
1-877-YALEMDS
  • Search
  • Clinical Trials
  • Pancreatic Ductal Adenocarcinoma

Clinical Trials

    • Cancer(6)
  • Pancreatic Cancer

    A Phase II, Open-Label, Multicenter, Randomized Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Patients With Resected Pancreatic Ductal Adenocarcinoma

    • Pancreatic Cancer

      Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

      • Pancreatic Cancer

        A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer

        • Pancreatic Cancer

          The Cancer of the Pancreas Screening-5 (CAPS5) Study

          • Ages18 years and older
          • GenderBoth
        • Pancreatic Cancer

          A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion

          • Phase 1 Cancers

            Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma

            • About Us
            • Contact Us
            • Donate
            • Referring Doctors
            • Clinical Keywords

            333 Cedar St.

            New Haven, CT 06510

            • Yale School of Medicine
            • Yale University
            • Terms & Privacy Policies
            • Accessibility at YSM
            • Patient Rights
            • HIPAA at Yale
            • Non-discrimination Statement
            Copyright 2025 Yale Medicine